Pre-Exposure Prophylaxis (PrEP) is a medical strategy involving the use of antiretroviral medications by HIV-negative individuals to reduce their risk of acquiring HIV. It is particularly recommended for people who are at high risk of HIV exposure, such as those with HIV-positive partners or individuals engaging in behaviors that increase their risk of infection.

PrEP works by maintaining high levels of medication in the bloodstream, which can prevent the virus from establishing an infection if exposure occurs. When taken consistently, PrEP has been shown to be highly effective, with studies indicating that it can reduce the risk of acquiring HIV by up to 99% in those who adhere to the regimen.

To effectively utilize PrEP, individuals must consult healthcare providers for assessment and prescription, undergo regular testing for HIV and other sexually transmitted infections (STIs), and receive ongoing support and counseling about safe sex practices. It is important for users to understand that while PrEP significantly lowers the risk of HIV, it does not protect against other STIs or unintended pregnancies, and should be used in conjunction with other preventive measures, such as condoms, for comprehensive protection.

Overall, PrEP represents a proactive approach to sexual health, empowering individuals to take control of their HIV prevention strategies in the context of their sexual relationships and activities.